[1]齐 易.维持性透析患者恶性肿瘤的发生情况及相关因素[J].医学信息,2020,33(12):101-102.[doi:10.3969/j.issn.1006-1959.2020.12.030]
　QI Yi.Analysis of Occurrence and Related Factors of Malignant Tumors in Maintenance Dialysis Patients[J].Medical Information,2020,33(12):101-102.[doi:10.3969/j.issn.1006-1959.2020.12.030]
点击复制

维持性透析患者恶性肿瘤的发生情况及相关因素()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年12期
页码:
101-102
栏目:
临床研究
出版日期:
2020-06-15

文章信息/Info

Title:
Analysis of Occurrence and Related Factors of Malignant Tumors in Maintenance Dialysis Patients
文章编号:
1006-1959（2020）12-0101-02
作者:
齐 易
（天津市第一中心医院泌尿外科，天津 300300）
Author(s):
QI Yi
(Tianjin First Central Hospital,Tianjin 300300,China)
关键词:
维持性透析; 恶性肿瘤; 相关因素
Keywords:
Maintenance dialysis; Malignant tumor; Related factors
分类号:
R692.5；R730.5
DOI:
10.3969/j.issn.1006-1959.2020.12.030
文献标志码:
A
摘要:
目的 研究维持性透析患者恶性肿瘤的发生情况与相关因素。方法 选取2018年5月~2019年5月在我院诊治的90例维持性透析患者为研究对象，分析恶性肿瘤的发生情况及并发恶性肿瘤的可能危险因素。结果 90例维持性透析患者中并发症恶性肿瘤10例，发生率为11.11%，其中肺癌2例，肝癌1例，胰腺癌1例，乳腺癌1例，肾癌2例，膀胱癌2例，前列腺癌1例，泌尿系统发生率最高，为50.00%；并发恶性肿瘤与患者年龄、透析龄、白蛋白、全段甲状旁腺激素可能有关（P＜0.05）；与性别、体质指数、血红蛋白、胆固醇可能无关（P＞0.05）；Logistic多因素分析显示，年龄＞60岁、透析龄＞6年、白蛋白≥30 g/L是维持性透析并发恶性肿瘤的独立危险因素（P＜0.05），与全段甲状旁腺激素可能无关（P＞0.05）。结论 维持性透析患者恶性肿瘤发生率高于正常人群，年龄、透析龄、白蛋白是其独立危险因素，临床加强对高危人群的检测，及时发现病情变化给予治疗以改善临床预后。
Abstract:
Objective To study the occurrence and related factors of malignant tumors in maintenance dialysis patients.Methods 90 patients with maintenance dialysis diagnosed and treated in our hospital from May 2018 to May 2019 were selected as the research object, analyze the occurrence of malignant tumors and possible risk factors for malignant tumors.Results Of the 90 maintenance dialysis patients, 10 had complications and malignant tumors, with an incidence of 11.11%, including 2 cases of lung cancer, 1 case of liver cancer, 1 case of pancreatic cancer, 1 case of breast cancer, 2 cases of kidney cancer, 2 cases of bladder cancer, and prostate 1 case of cancer, the highest incidence of urinary system, 50.00%; concurrent malignant tumors may be related to the patient’s age, age of dialysis, albumin, and whole parathyroid hormone (P<0.05);It may have nothing to do with gender, body mass index, hemoglobin, cholesterol (P>0.05); Logistic multivariate analysis showed that age 60 years and over, dialysis age over 6 years, and albumin ≥30 g/L are independent of maintenance dialysis complicated with malignant tumor risk factors(P<0.05) may have nothing to do with the whole parathyroid hormone(P>0.05).Conclusion The incidence of malignant tumors in maintenance dialysis patients is higher than that in the normal population. Age, dialysis age, and albumin are its independent risk factors. The clinical detection of high-risk groups is strengthened, and changes in disease status are found in time to provide treatment to improve clinical prognosis.

参考文献/References:

[1]胡春艳,夏璐,徐百升,等.终末期肾病患者恶性肿瘤发病率及相关因素研究[J].中国急救医学,2015,35(z2):239-240.[2]杨红兰.慢性肾功能衰竭血液透析患者合并恶性肿瘤22例临床分析[J].山东大学学报(医学版),2014,52(z1):127-128.[3]杨晨.维持性血液透析患者血清β2-微球蛋白的相关因素[D].大连医科大学,2015.[4]陈燕,纵晓英,李莹,等.终末期肾病维持性血液透析患者40例死亡原因分析[J].淮海医药,2015,12(1):59-61.[5]许倩娜.25羟维生素D与慢性肾脏病患者心血管疾病及其危险因素的关系研究[D].广州医科大学,2014.

相似文献/References:

[1]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
　YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Medical Information,2018,31(12):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[2]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,32(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
　HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Medical Information,2019,32(12):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[3]梁春玲,杨文珊.消化道恶性肿瘤的临床分析[J].医学信息,2019,32(18):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
　LIANG Chun-ling,YANG Wen-shan.Clinical Analysis of Malignant Tumors of the Digestive Tract[J].Medical Information,2019,32(12):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
[4]陈云娥,李 璠,张子怡,等.营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析[J].医学信息,2019,32(19):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
　CHEN Yun-e,LI Fan,ZHANG Zi-yi,et al.Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor[J].Medical Information,2019,32(12):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
[5]杜鑫荣.超声造影在肝实质性肿块诊断及鉴别中的临床价值[J].医学信息,2019,32(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
　DU Xin-rong.Clinical Value of Contrast-enhanced Ultrasonography in the Diagnosis and Differential Diagnosis of Liver Mass[J].Medical Information,2019,32(12):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
[6]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,32(12):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[7]易亭伍,邓窈窕,宿向东.恶性肿瘤患者及家属信息需求现状的多中心研究[J].医学信息,2019,32(22):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
　YI Ting-wu,DENG Yao-tiao,SU Xiang-dong.Multi-center Study on the Status of Information Needs of Patients with Malignant Tumors and their Families[J].Medical Information,2019,32(12):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
[8]赵博志,赵国林,杨 敏,等.乳腺鳞状细胞癌的临床诊疗研究[J].医学信息,2020,33(03):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
　ZHAO Bo-zhi,ZHAO Guo-lin,YANG Min,et al.Clinical Diagnosis and Treatment of Squamous Cell Carcinoma of the Breast[J].Medical Information,2020,33(12):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
[9]吴鑫阳,方明治.中医药治疗恶性肿瘤相关性贫血现状[J].医学信息,2020,33(06):31.[doi:10.3969/j.issn.1006-1959.2020.06.010]
　ZHANG Zhe.Status of Treatment of Malignant Tumor-related Anemia with Traditional Chinese Medicine[J].Medical Information,2020,33(12):31.[doi:10.3969/j.issn.1006-1959.2020.06.010]
[10]李 博.唑来膦酸联合放疗治疗恶性肿瘤骨转移患者的效果[J].医学信息,2020,33(09):138.[doi:10.3969/j.issn.1006-1959.2020.09.044]
　YU Shou-jie,JIA Qian.The Effect of Zoledronic Acid Combined with Radiotherapy in Patients with Bone Metastases from Malignant TumorsLI Bo[J].Medical Information,2020,33(12):138.[doi:10.3969/j.issn.1006-1959.2020.09.044]

更新日期/Last Update: 1900-01-01